Ergomed Group is a global provider of specialized clinical research, pharmacovigilance, and medical information services to the pharmaceutical and biotech industries. It offers full-service clinical trial management across all phases, with expertise in oncology and rare diseases, alongside post-approval drug safety solutions through its PrimeVigilance brand. The company supports emerging and established life sciences firms in meeting regulatory requirements and accelerating drug development.